Global Radiopharmaceuticals Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report ID: ARS2960 | Category: Healthcare | Pages: 116 | Format: PDF | Published Date: September 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4680.00 Multi User-$7900.00

Report Description
View Table of Contents

Report Summary

The global Radiopharmaceuticals  market size in 2022 is 5200.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 9.40% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Radiopharmaceuticals  market include Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), and Bracco Imaging (Italy). The share of the top 3 players in the Radiopharmaceuticals  market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Radiopharmaceuticals  market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Diagnostic Procedures accounted for XX% of Radiopharmaceuticals  market in 2022. Therapeutic Procedures share of XX%.
Hospitals accounted for XX% of the Radiopharmaceuticals  market in 2022. Ambulatory Surgical Centers accounts for XX%.

The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Radiopharmaceuticals  markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.

Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.

Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.

The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

   North America
   Europe
   China
   Japan
   Korea
   Southeast Asia
   India
   South America
   Middle East & Africa

Player list
	Cardinal Health (U.S.)
	GE Healthcare (U.S.)
	Lantheus Medical Imaging (U.S.)
	Bayer AG (Germany)
	Bracco Imaging (Italy)
	Nordion (Canada)
	Advanced Accelerator Applications (France)
	NTP Radioisotopes (South Africa)
	NorthStar Medical Radioisotopes (U.S.)
	Eckert & Ziegler (Germany)
	Braun Melsungen AG (Germany)
	Smith+Nephew (Germany)

Types list
	Diagnostic Procedures
	Therapeutic Procedures
	Source

Application list
	Hospitals
	Ambulatory Surgical Centers
	Diagnostic Centers
	Cancer Research Institutes
	Others

Table of Content

1 Radiopharmaceuticals  Market Introduction and Overview
1.1 Radiopharmaceuticals  Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals  Sales and Market Share by Manufacturer
2.2 Global Radiopharmaceuticals  Revenue and Market Share by Manufacturer
2.3 Global Radiopharmaceuticals  Average Price by Manufacturers
2.4 Manufacturers Radiopharmaceuticals  Production Sites, Area Served, Product Types
2.5 Radiopharmaceuticals  Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals  Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.5.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Cardinal Health (U.S.)
3.1.1 Cardinal Health (U.S.) Company Profile
3.1.2 Radiopharmaceuticals  Product Overview
3.1.3 Cardinal Health (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
3.1.4 Cardinal Health (U.S.) Business Overview
3.2 GE Healthcare (U.S.)
3.2.1 GE Healthcare (U.S.) Company Profile
3.2.2 Radiopharmaceuticals  Product Overview
3.2.3 GE Healthcare (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
3.2.4 GE Healthcare (U.S.) Business Overview
3.3 Lantheus Medical Imaging (U.S.)
3.3.1 Lantheus Medical Imaging (U.S.) Company Profile
3.3.2 Radiopharmaceuticals  Product Overview
3.3.3 Lantheus Medical Imaging (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
3.3.4 Lantheus Medical Imaging (U.S.) Business Overview
3.4 Bayer AG (Germany)
3.4.1 Bayer AG (Germany) Company Profile
3.4.2 Radiopharmaceuticals  Product Overview
3.4.3 Bayer AG (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
3.4.4 Bayer AG (Germany) Business Overview
3.5 Bracco Imaging (Italy)
3.5.1 Bracco Imaging (Italy) Company Profile
3.5.2 Radiopharmaceuticals  Product Overview
3.5.3 Bracco Imaging (Italy) Radiopharmaceuticals  Market Performance (2018-2023)
3.5.4 Bracco Imaging (Italy) Business Overview
3.6 Nordion (Canada)
3.6.1 Nordion (Canada) Company Profile
3.6.2 Radiopharmaceuticals  Product Overview
3.6.3 Nordion (Canada) Radiopharmaceuticals  Market Performance (2018-2023)
3.6.4 Nordion (Canada) Business Overview
3.7 Advanced Accelerator Applications (France)
3.7.1 Advanced Accelerator Applications (France) Company Profile
3.7.2 Radiopharmaceuticals  Product Overview
3.7.3 Advanced Accelerator Applications (France) Radiopharmaceuticals  Market Performance (2018-2023)
3.7.4 Advanced Accelerator Applications (France) Business Overview
3.8 NTP Radioisotopes (South Africa)
3.8.1 NTP Radioisotopes (South Africa) Company Profile
3.8.2 Radiopharmaceuticals  Product Overview
3.8.3 NTP Radioisotopes (South Africa) Radiopharmaceuticals  Market Performance (2018-2023)
3.8.4 NTP Radioisotopes (South Africa) Business Overview
3.9 NorthStar Medical Radioisotopes (U.S.)
3.9.1 NorthStar Medical Radioisotopes (U.S.) Company Profile
3.9.2 Radiopharmaceuticals  Product Overview
3.9.3 NorthStar Medical Radioisotopes (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
3.9.4 NorthStar Medical Radioisotopes (U.S.) Business Overview
3.10 Eckert & Ziegler (Germany)
3.10.1 Eckert & Ziegler (Germany) Company Profile
3.10.2 Radiopharmaceuticals  Product Overview
3.10.3 Eckert & Ziegler (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
3.10.4 Eckert & Ziegler (Germany) Business Overview
3.11 Braun Melsungen AG (Germany)
3.11.1 Braun Melsungen AG (Germany) Company Profile
3.11.2 Radiopharmaceuticals  Product Overview
3.11.3 Braun Melsungen AG (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
3.11.4 Braun Melsungen AG (Germany) Business Overview
3.12 Smith+Nephew (Germany)
3.12.1 Smith+Nephew (Germany) Company Profile
3.12.2 Radiopharmaceuticals  Product Overview
3.12.3 Smith+Nephew (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
3.12.4 Smith+Nephew (Germany) Business Overview
4 Global Radiopharmaceuticals  Historical and Forecast Market Analysis by Type
4.1 Global Radiopharmaceuticals  Revenue and Market Share by Type
4.2 Global Radiopharmaceuticals  Sales and Market Share by Type
4.3 Global Radiopharmaceuticals  Revenue Market Forecast by Type (2023-2029)
4.4 Global Radiopharmaceuticals  Sales Market Forecast by Type (2023-2029)
5 Global Radiopharmaceuticals  Historical and Forecast Market Analysis by Application
5.1 Global Radiopharmaceuticals  Revenue Market Share by Application (2018-2023)
5.2 Global Radiopharmaceuticals  Sales Market Share by Application (2018-2023)
5.3 Radiopharmaceuticals  Revenue Market Forecast by Application (2023-2029)
5.4 Radiopharmaceuticals  Sales Market Forecast by Application (2023-2029)
6 Global Market Growth Trends Analysis
6.1 Global Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2 Radiopharmaceuticals  Growth Trends Analysis by Regions
6.2.1 Radiopharmaceuticals  Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Radiopharmaceuticals  Historic Market Size by Regions (2018-2023)
6.2.3 Radiopharmaceuticals  Forecasted Market Size by Regions (2023-2029)
6.2.4 North America Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.5 Europe Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.6 China Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.7 Japan Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.8 Korea Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.9 Southeast Asia Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.10 India Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.11 South America Radiopharmaceuticals  Market Size & Forecast (2018-2029)
6.2.12 Middle East & Africa Radiopharmaceuticals  Market Size & Forecast (2018-2029)
7 North America
7.1 North America Radiopharmaceuticals  Revenue by Players
7.2 North America Radiopharmaceuticals  Sales by Types
7.3 North America Radiopharmaceuticals  Sales by Applications
7.4 North America Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Radiopharmaceuticals  Revenue by Players
8.2 Europe Radiopharmaceuticals  Sales by Types
8.3 Europe Radiopharmaceuticals  Sales by Applications
8.4 Europe Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
8.5 Europe PEST Analysis
9 China
9.1 China Radiopharmaceuticals  Revenue by Players
9.2 China Radiopharmaceuticals  Sales by Types
9.3 China Radiopharmaceuticals  Sales by Applications
9.4 China Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
9.5 China PEST Analysis
10 Japan
10.1 Japan Radiopharmaceuticals  Revenue by Players
10.2 Japan Radiopharmaceuticals  Sales by Types
10.3 Japan Radiopharmaceuticals  Sales by Applications
10.4 Japan Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Radiopharmaceuticals  Revenue by Players
11.2 Korea Radiopharmaceuticals  Sales by Types
11.3 Korea Radiopharmaceuticals  Sales by Applications
11.4 Korea Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Radiopharmaceuticals  Revenue by Players
12.2 Southeast Asia Radiopharmaceuticals  Sales by Types
12.3 Southeast Asia Radiopharmaceuticals  Sales by Applications
12.4 Southeast Asia Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Radiopharmaceuticals  Revenue by Players
13.2 India Radiopharmaceuticals  Sales by Types
13.3 India Radiopharmaceuticals  Sales by Applications
13.4 India Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
13.5 India PEST Analysis
14 South America
14.1 South America Radiopharmaceuticals  Revenue by Players
14.2 South America Radiopharmaceuticals  Sales by Types
14.3 South America Radiopharmaceuticals  Sales by Applications
14.4 South America Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Radiopharmaceuticals  Revenue by Players
15.2 Middle East & Africa Radiopharmaceuticals  Sales by Types
15.3 Middle East & Africa Radiopharmaceuticals  Sales by Applications
15.4 Middle East & Africa Radiopharmaceuticals  Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
15.5 Middle East & Africa PEST Analysis
16 Radiopharmaceuticals  Manufacturing Cost Analysis
16.1 Radiopharmaceuticals  Key Raw Materials Analysis
16.1.1 Key Raw Materials
16.1.2 Price Trend of Key Raw Materials
16.1.3 Key Suppliers of Raw Materials
16.2 Proportion of Manufacturing Cost Structure
16.2.1 Raw Materials
16.2.2 Labor Cost
16.2.3 Manufacturing Expenses
16.3 Manufacturing Process Analysis of Radiopharmaceuticals 
16.4 Radiopharmaceuticals  Industrial Chain Analysis
17 Radiopharmaceuticals  Industry Dynamic Analysis
17.1 Radiopharmaceuticals  Market Trends Analysis
17.2 Radiopharmaceuticals  Market Drivers Analysis
17.3 Radiopharmaceuticals  Market Challenges Analysis
17.4 Radiopharmaceuticals  Market Restraints Analysis
18 Market Channel, Distributors, Traders and Dealers
18.1 Market Channel Status
18.1.1 Direct Marketing
18.1.2 Indirect Marketing
18.2 Radiopharmaceuticals  Typical Distributors
18.3 Radiopharmaceuticals  Typical Customers
19 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Radiopharmaceuticals Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?